Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

'Game-changing' diabetes treatment approved

Australians living with an early stage of type 1 diabetes can now be treated with the first non-insulin drug saving them years of needles.

AAP

What Happens to Your Body After 3 Days in 45°C Heat

When the temperature climbs to 45°C, your body enters survival mode. Sweating, increased heart rate, fatigue, headaches, and irritability are not random summer discomforts. They are biological alarms. Most people think heat becomes dangerous only when someone collapses outdoors. But doctors warn that damage often starts much earlier and builds…

MyLifeXP

Are Wall Street Analysts Bullish on Insulet Stock?

Although Insulet has lagged the broader market over the past year, Wall Street analysts remain strongly optimistic about the company’s long-term growth prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

Saving Advice

5 People Who Should Never Eat Papaya: Hidden Dangers You Should Know About

Papaya has built a reputation as one of the healthiest fruits in the world. Rich in vitamin C, antioxidants, potassium, and digestive enzymes, it’s often recommended for glowing skin, better digestion, and improved immunity. Whether eaten ripe as breakfast or consumed raw in salads, papaya has become a staple in…

MyLifeXP

‘Beef. It’s what’s for dinner’: Previous health risks linked to the red meat debunked

More than 36 million Americans live with Type 2 diabetes

The Independent UK

GLP-1 Drugs Could Soon Treat Heart Failure and Peripheral Artery Disease—FDA Approvals Coming

GLP-1 drugs are no longer just weight-loss and diabetes medications. Researchers are now studying whether these blockbuster treatments can help people living with heart failure and peripheral artery disease (PAD), two serious conditions affecting millions of Americans. That shift could reshape how doctors manage cardiovascular disease in the coming years.…

Budget and the Bees

Read news from The Economist, FT, and more,
with one subscription

Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?

Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weight-loss and diabetes medicines. Doctors are advising patients on these drugs to take multivitamins and protein supplements. This is to prevent nutritional deficiencies and muscle loss due to reduced food intake. Sales…

The Economic Times

Insurer denies Rs 20 lakh life insurance claim over diabetes non-disclosure; woman fights back and wins; here’s why

A Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the State Consumer Commission. The insurer failed to provide sufficient proof of deliberate concealment, leading to a ruling in favor of the policyholder.

The Economic Times

Our top-rated berberine supplement could support your metabolic health – here's what to know

The supplement has become increasingly popular for help managing numerous health issues

Evening Standard

Stocks in news: ITC, Nykaa, Lenskart, Ola Electric, IndusInd Bank

Markets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downside. Several companies like ITC, Nykaa, and IndusInd Bank are in focus due to Q4 results and news developments, including Lenskart's profit decline and Dr. Reddy's new diabetes drug launch.

The Economic Times

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effectively enhance glycaemic control. Dr.

The Economic Times

Plantwatch: how goat’s rue inspired super drug for everything from diabetes to obesity

Galegine compound in plant formed blueprint for metformin drug, but without the toxic side-effects

The Guardian - UK

Stem cells have potent potential for diabetes treatment

Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into any cell type makes them pluripotent — something that researchers…

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

NHS rollout of artificial pancreas narrows inequality in diabetes care

People from deprived and minority ethnic backgrounds have better access to device than for previous technologies

MyLifeXP

5 Silent Eye Warning Signs You Should Never Ignore

Most people think eye problems begin with major vision loss. But the truth is far more dangerous. Your eyes often send quiet warning signals long before serious damage begins. A little blur, slight irritation, occasional headaches, or trouble seeing at night may seem harmless at first. Many people blame stress,…

The Economic Times

US drugs site TrumpRx to list 600 generics as Donald Trump targets lower prices

President Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs. This includes common treatments for cholesterol and diabetes. The initiative aims to lower prescription drug costs for Americans. Prices will be integrated from various sources. This move seeks to provide…

Budget and the Bees

A 4-Week Diabetes Miracle? All 10 Patients in a Chicago Trial Achieved Insulin Independence — Could This Cure Be Coming Soon

For millions of Americans living with Type 1 diabetes, every day revolves around insulin shots, glucose monitors, meal planning, and the constant fear of dangerous blood sugar swings. That is why a small but groundbreaking clinical trial in Chicago is creating massive buzz in the medical world. Researchers reported that…

Get all your
news in one place.

100's of premium titles.
One news app.

Clever Dude

Men’s Silent Killers: 5 Mild Symptoms That Signal Serious Health Problems

Men often brush off small changes in their bodies, assuming stress, age, or lack of sleep explains everything. That mindset can quietly open the door to serious medical conditions that build over time without loud warning bells. Many life-threatening diseases start with symptoms so mild that they feel almost normal.…

Budget and the Bees

No Candy, No Soda: 4 States Are Banning Sugary Treats for SNAP Users – How This Could Spread Nationwide

Families using SNAP benefits could soon notice major changes at grocery store checkout lines. Several states are now moving to block purchases of soda, candy, and other sugary snacks with Supplemental Nutrition Assistance Program benefits, arguing that taxpayer-funded food assistance should promote healthier eating habits. Indiana, Nebraska, Utah, and West…

The Conversation

From PCOS to PMOS: What the name change to polyendocrine metabolic ovarian syndrome means for women’s health

“Hopeful,” “excited” and “helpful” for the future of women’s health — these are just some of the words expressed by the team that worked together for more than a decade to change the name polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS).

MarketBeat

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related factors, while emphasizing that the diabetes device maker is continuing a broader diversification

Medical Daily

Managing Gestational Diabetes Glucose With Friendly Eating Insulin Support and a Practical Gestational Diabetes Diet

Learn how gestational diabetes affects glucose and insulin, why gestational diabetes screening matters, and how a balanced gestational diabetes diet supports a healthy pregnancy.

Saving Advice

4 High-Use Drugs That Will Have Lower Medicare Prices — And 3 Others Facing Negotiations

Millions of seniors are finally seeing relief from some of the highest prescription drug costs in America as Medicare’s new drug price negotiation program begins...

MarketBeat

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and margin improvement. President and Chief Executive Officer Jake Leach said the company’s next phase

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.